Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Comparative genotypic and phenotypic analysis of human peripheral blood monocytes and surrogate monocyte-like cell lines commonly used in metabolic disease research.

Riddy DM, Goy E, Delerive P, Summers RJ, Sexton PM, Langmead CJ.

PLoS One. 2018 May 10;13(5):e0197177. doi: 10.1371/journal.pone.0197177. eCollection 2018.

2.

G Protein-Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus.

Riddy DM, Delerive P, Summers RJ, Sexton PM, Langmead CJ.

Pharmacol Rev. 2018 Jan;70(1):39-67. doi: 10.1124/pr.117.014373. Review.

PMID:
29233848
3.

Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: from hit to clinic.

Pizzonero M, Dupont S, Babel M, Beaumont S, Bienvenu N, Blanqué R, Cherel L, Christophe T, Crescenzi B, De Lemos E, Delerive P, Deprez P, De Vos S, Djata F, Fletcher S, Kopiejewski S, L'Ebraly C, Lefrançois JM, Lavazais S, Manioc M, Nelles L, Oste L, Polancec D, Quénéhen V, Soulas F, Triballeau N, van der Aar EM, Vandeghinste N, Wakselman E, Brys R, Saniere L.

J Med Chem. 2014 Dec 11;57(23):10044-57. doi: 10.1021/jm5012885. Epub 2014 Dec 1.

PMID:
25380412
4.

Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization.

Blanqué R, Lepescheux L, Auberval M, Minet D, Merciris D, Cottereaux C, Clément-Lacroix P, Delerive P, Namour F.

BMC Musculoskelet Disord. 2014 Sep 3;15:291. doi: 10.1186/1471-2474-15-291.

5.

PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH.

Baron M, Leroyer AS, Majd Z, Lalloyer F, Vallez E, Bantubungi K, Chinetti-Gbaguidi G, Delerive P, Boulanger CM, Staels B, Tailleux A.

Atherosclerosis. 2011 Sep;218(1):69-76. doi: 10.1016/j.atherosclerosis.2011.03.009. Epub 2011 Mar 15.

6.

Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo.

Yasuda T, Grillot D, Billheimer JT, Briand F, Delerive P, Huet S, Rader DJ.

Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):781-6. doi: 10.1161/ATVBAHA.109.195693. Epub 2010 Jan 28.

7.

Short-term adaptation of postprandial lipoprotein secretion and intestinal gene expression to a high-fat diet.

Hernández Vallejo SJ, Alqub M, Luquet S, Cruciani-Guglielmacci C, Delerive P, Lobaccaro JM, Kalopissis AD, Chambaz J, Rousset M, Lacorte JM.

Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G782-92. doi: 10.1152/ajpgi.90324.2008. Epub 2009 Feb 5.

8.

Intestine-specific regulation of PPARalpha gene transcription by liver X receptors.

Colin S, Bourguignon E, Boullay AB, Tousaint JJ, Huet S, Caira F, Staels B, Lestavel S, Lobaccaro JM, Delerive P.

Endocrinology. 2008 Oct;149(10):5128-35. doi: 10.1210/en.2008-0637. Epub 2008 Jun 19.

PMID:
18566121
9.

Regulation of anti-atherogenic apolipoprotein M gene expression by the orphan nuclear receptor LRH-1.

Venteclef N, Haroniti A, Tousaint JJ, Talianidis I, Delerive P.

J Biol Chem. 2008 Feb 15;283(7):3694-701. Epub 2007 Oct 31.

11.

Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1.

Whitby RJ, Dixon S, Maloney PR, Delerive P, Goodwin BJ, Parks DJ, Willson TM.

J Med Chem. 2006 Nov 16;49(23):6652-5.

PMID:
17154495
12.

Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response.

Venteclef N, Smith JC, Goodwin B, Delerive P.

Mol Cell Biol. 2006 Sep;26(18):6799-807.

13.

The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone.

Fugier C, Tousaint JJ, Prieur X, Plateroti M, Samarut J, Delerive P.

J Biol Chem. 2006 Apr 28;281(17):11553-9. Epub 2006 Feb 27.

14.

Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription.

Delerive P, Galardi CM, Bisi JE, Nicodeme E, Goodwin B.

Mol Endocrinol. 2004 Oct;18(10):2378-87. Epub 2004 Jun 24.

PMID:
15218078
15.

A paradigm for gene regulation: inflammation, NF-kappaB and PPAR.

Vanden Berghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B, Haegeman G.

Adv Exp Med Biol. 2003;544:181-96. Review.

PMID:
14713228
16.

Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cells.

Martin-Nizard F, Furman C, Delerive P, Kandoussi A, Fruchart JC, Staels B, Duriez P.

J Cardiovasc Pharmacol. 2002 Dec;40(6):822-31.

PMID:
12451315
17.

Identification of Reverb(alpha) as a novel ROR(alpha) target gene.

Delerive P, Chin WW, Suen CS.

J Biol Chem. 2002 Sep 20;277(38):35013-8. Epub 2002 Jul 11.

18.

DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha.

Delerive P, De Bosscher K, Vanden Berghe W, Fruchart JC, Haegeman G, Staels B.

Mol Endocrinol. 2002 May;16(5):1029-39.

PMID:
11981037
19.
20.

Requirement of helix 1 and the AF-2 domain of the thyroid hormone receptor for coactivation by PGC-1.

Wu Y, Delerive P, Chin WW, Burris TP.

J Biol Chem. 2002 Mar 15;277(11):8898-905. Epub 2001 Dec 20.

21.

PGC-1 functions as a transcriptional coactivator for the retinoid X receptors.

Delerive P, Wu Y, Burris TP, Chin WW, Suen CS.

J Biol Chem. 2002 Feb 8;277(6):3913-7. Epub 2001 Nov 19.

22.

Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells.

Gosset P, Charbonnier AS, Delerive P, Fontaine J, Staels B, Pestel J, Tonnel AB, Trottein F.

Eur J Immunol. 2001 Oct;31(10):2857-65.

PMID:
11592060
23.

Schistosoma mansoni induces the synthesis of IL-6 in pulmonary microvascular endothelial cells: role of IL-6 in the control of lung eosinophilia during infection.

Angeli V, Faveeuw C, Delerive P, Fontaine J, Barriera Y, Franchimont N, Staels B, Capron M, Trottein F.

Eur J Immunol. 2001 Sep;31(9):2751-61.

24.

Peroxisome proliferator-activated receptors in inflammation control.

Delerive P, Fruchart JC, Staels B.

J Endocrinol. 2001 Jun;169(3):453-9. Review.

PMID:
11375115
25.

The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response.

Delerive P, Monté D, Dubois G, Trottein F, Fruchart-Najib J, Mariani J, Fruchart JC, Staels B.

EMBO Rep. 2001 Jan;2(1):42-8.

26.
27.

Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells.

Faveeuw C, Fougeray S, Angeli V, Fontaine J, Chinetti G, Gosset P, Delerive P, Maliszewski C, Capron M, Staels B, Moser M, Trottein F.

FEBS Lett. 2000 Dec 15;486(3):261-6.

29.

Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner.

Delerive P, Furman C, Teissier E, Fruchart J, Duriez P, Staels B.

FEBS Lett. 2000 Apr 7;471(1):34-8.

30.

Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells : synergy with interleukin-1beta.

Bernard C, Merval R, Lebret M, Delerive P, Dusanter-Fourt I, Lehoux S, Créminon C, Staels B, Maclouf J, Tedgui A.

Circ Res. 1999 Dec 3-17;85(12):1124-31.

PMID:
10590238
31.

Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with the NF-kappaB pathway.

Trottein F, Nutten S, Angeli V, Delerive P, Teissier E, Capron A, Staels B, Capron M.

Eur J Immunol. 1999 Nov;29(11):3691-701.

32.

Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1.

Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B.

J Biol Chem. 1999 Nov 5;274(45):32048-54.

33.

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.

Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchart JC, Najib J, Duriez P, Staels B.

Circ Res. 1999 Sep 3;85(5):394-402.

PMID:
10473669
34.

Cross-influence of membrane polyunsaturated fatty acids and hypoxia-reoxygenation on alpha- and beta-adrenergic function of rat cardiomyocytes.

Ponsard B, Durot I, Delerive P, Oudot F, Cordelet C, Grynberg A, Athias P.

Lipids. 1999 May;34(5):457-66.

PMID:
10380117
35.

Hypoxia-reoxygenation and polyunsaturated fatty acids modulate adrenergic functions in cultured cardiomyocytes.

Delerive P, Oudot F, Ponsard B, Talpin S, Sergiel JP, Cordelet C, Athias P, Grynberg A.

J Mol Cell Cardiol. 1999 Feb;31(2):377-86.

PMID:
10093050
36.

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages.

Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B.

J Biol Chem. 1998 Oct 2;273(40):25573-80.

37.

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A.

Nature. 1998 Jun 25;393(6687):790-3.

PMID:
9655393

Supplemental Content

Loading ...
Support Center